Company Announcements

Investor presentation

Source: RNS
RNS Number : 6587Z
IP Group PLC
15 September 2022


15th September 2022


IP Group plc - Investor presentation


IP Group plc (LSE: IPO) ("IP Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, is pleased to announce that it will host an industry-wide event titled 'Technology Trailblazers:Backing Deeptech to 2030 and Beyond' on Wednesday 05 October 2022.


The IP Group Deeptech team looks forward to welcoming investors, co-investors, analysts and the wider tech ecosystem for a thought-provoking evening of talks from two of the UK's foremost technology innovators. Dr Tom Carter, decorated innovator and Founder & CEO of multi award-winning technology company Ultraleap Ltd will speak on 'The Metaverse: a playground, classroom or workplace?'. Professor Niki Trigoni, head of the University of Oxford Cyber Physical Systems Group and founder of Navenio Ltd, will speak on the topic of 'Where next for applied AI?'. In 2020 Niki won the KPMG Award for "Best British Tech Pioneer" and in 2022 she won "CTO of the Year" at the UK's Women in IT Awards.


These talks will be followed by a short panel discussion comprising the speakers alongside IP Group's Managing Partner for Technology, Dr Mark Reilly.  


The event will be hybrid (both in person and virtual) and take place from 5.00pm. For further information and to register to attend, please visit the events section of our website:


The online update will be hosted through the Investor Meet Company platform. Questions can be submitted in advance of the event via the Investor Meet Company Platform up to 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: Investors who already follow IP Group plc on the Investor Meet Company platform will automatically be invited.


The in-person event will be followed by networking alongside drinks and canapes.


No material new information will be released by the Company during the presentation.


For more information, please contact:


IP Group plc

Liz Vaughan-Adams, Communications           

+44 (0) 20 7444 0050
+44 (0) 20 7444 0062/+44 (0)
7967 312125

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995


Notes for editors


About IP Group


IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech. The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.


For more information, please visit our website at



This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.